PRIMECAP Odyssey Growth (POGRX)

Nasdaq Currently down 0.49 (-1.06%) in today's trading session

1 member of Congress has disclosed 7 trades in PRIMECAP Odyssey Growth (POGRX) via STOCK Act filings. The most recent disclosure was a sale by Seth Moulton on 8 February 2021. Aggregate disclosed activity totals roughly $32K in purchases and $24K in sales (midpoint estimates from bracketed disclosure amounts).

PRIMECAP Odyssey Growth is currently trading at $45.95, positioned at 79% of its 52-week range ($33.71 – $49.14).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$45.95
24h Change
-0.49 (-1.06%)
52 Week Range
$33.71$49.14
View on NASDAQ

PRIMECAP Odyssey Growth Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for POGRX

Select to highlight on chart
0 transactions
Compliance: 0%
No data

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$6.79B

Volume

0

Beta

1.15

P/E Ratio

Fundamentals

EPS

Div. Yield

19.89%

Open

$45.95

Day Range

$45.95 — $45.95

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2004-11-03

The fund primarily invests in shares of U.S. corporations, specifically targeting those businesses that demonstrate a strong potential for above-average profit growth. It maintains a flexible investment approach, allowing it to allocate capital acros...

No earnings data available for this stock.

Dividends

Dividend History

15 Dec 2025
Amount $9.1372
16 Dec 2024
Amount $7.1770
15 Dec 2023
Amount $4.8792
15 Dec 2022
Amount $4.1625
15 Dec 2021
Amount $6.0333
15 Dec 2020
Amount $5.3040
17 Dec 2019
Amount $2.0980
17 Dec 2018
Amount $0.8510
18 Dec 2017
Amount $0.5740
16 Dec 2016
Amount $0.9990
16 Dec 2015
Amount $0.3510
16 Dec 2014
Amount $0.8090
10 Dec 2013
Amount $0.5330
11 Dec 2012
Amount $0.1050
13 Dec 2011
Amount $0.1150
15 Dec 2010
Amount $0.0140
30 Apr 2010
Amount $0.0360
18 Dec 2009
Amount $0.0290
18 Dec 2008
Amount $0.0330
18 Dec 2007
Amount $0.0780
20 Dec 2006
Amount $0.1570
20 Dec 2005
Amount $0.0079

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

BAFWX

Brown Advisory Sustainable Growth I

47
$47.68-0.34 (-0.71%)
Financial Services
Held by same politician
Same sector: Financial Services
1 politician
View Stock

BASVX

Brown Advisory Sustainable Val Inst

17
$15.81+0.09 (+0.57%)
Held by same politician
1 politician
View Stock

BAFLX

Brown Advisory Global Leaders Instl

17
$28.00-0.08 (-0.28%)
Held by same politician
1 politician
View Stock

Frequently Asked Questions about POGRX

Which members of Congress have traded POGRX?
1 member of Congress has disclosed 7 trade in PRIMECAP Odyssey Growth (POGRX) under the STOCK Act: Seth Moulton.
When was POGRX most recently disclosed by Congress?
The most recent POGRX disclosure was a sale by Seth Moulton on 8 February 2021.
What is the total disclosed congressional trading volume for POGRX?
Members of Congress have disclosed approximately $32K in POGRX purchases and $24K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in POGRX?
This POGRX page updates as soon as new STOCK Act disclosures are filed for PRIMECAP Odyssey Growth. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.